摘要
慢性心力衰竭是一种复杂的临床综合征。由于抗心律失常西药不良反应较多,效果差,临床应用顾虑较多。于是为中药的加载治疗提供了广阔的空间,中药稳心颗粒作为国家"八五"课题的攻关成果,是国家批准生产的第一个治疗心律失常的中药新药制剂。临床上经过长期验证,稳心颗粒在配合常规治疗的基础上可增强心肌收缩力,改善心功能;可改善微循环,减慢心率,降低患者血浆脑钠肽的水平。从而减少心力衰竭的发生,减少病死率,提高患者的生活质量。在临床上应用广泛,疗效确切,使用方便,安全性良好,满足了临床和患者的需求。
Chronicheartfailureisacomplexclinicalsyndrome.Therearealotofclinicalapplicationconcernsofantiarrhythmicwestern medicine due to the many side-effects and dissatisfactory effects.Therefore,there is extensive space for the application of Chinese medicine.As the achievements of national project of eighth “five year plan”,Wenxin granules was the first Chinese medicine agent to treat arrhythmia approved to produce.The long-term clinical application has proven that Wenxin granules can enhance the contraction of heart muscle and improve heart function.It can improve micro-circulation,slower the heart rate,and decrease the level of Natriuretic Peptide.It is widely applied in clinical practice and shows definite therapeutic effect with good convenience and safety.
出处
《世界中医药》
CAS
2014年第7期965-967,共3页
World Chinese Medicine
关键词
稳心颗粒
心力衰竭
Wenxin granules
Heart failure
